Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totaling 9,700 shares, a decline of 40.5% from the August 31st total of 16,300 shares. Based on an average trading volume of 5,500 shares, the days-to-cover ratio is currently 1.8 days. Based on an average trading volume of 5,500 shares, the days-to-cover ratio is currently 1.8 days.

Alpha Tau Medical Stock Up 0.6%

NASDAQ:DRTSW opened at $0.38 on Monday. Alpha Tau Medical has a 52 week low of $0.13 and a 52 week high of $0.50. The firm’s 50-day simple moving average is $0.29 and its 200 day simple moving average is $0.25.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.